Stocks and Investing
Stocks and Investing
Fri, March 31, 2023
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
[ Fri, Mar 31st 2023
] - WOPRAI
Elemer Piros Reiterated (UNCY) at Strong Buy and Held Target at $24 on, Mar 31st, 2023
Elemer Piros of EF Hutton, Reiterated "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy and Held Target at $24 on, Mar 31st, 2023.
Elemer has made no other calls on UNCY in the last 4 months.
There are 2 other peers that have a rating on UNCY. Out of the 2 peers that are also analyzing UNCY, 0 agree with Elemer's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Elemer
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $8 on, Thursday, March 9th, 2023
- Jason McCarthy of "Maxim Group" Maintained at Strong Buy with Increased Target to $6 on, Thursday, March 9th, 2023
Contributing Sources